Article

Judge Approves $7 Billion Settlement Over Claims That Roundup Caused Cancer — Tech Report

BNewsO
● H.I.V. Research Networks May Again Seek Federal Funding, With a Twist ● Powerful Health Panel Has Tumultuous First Meeting With RFK Jr’s Appoi● A Short Workout to Strengthen Your Neck — News Report● Ron DeSantis Ponders a Presidential Run in a Post-Trump World — Politi● Why is Mike ‘Finish the Job in Iran’ Pence attacking ‘America First’ J
Technology & AI 21/11/2026, 02:33 PM EST

Judge Approves $7 Billion Settlement Over Claims That Roundup Caused Cancer — Tech Report

BNewsO [Technology & AI]: The ruling, in a nationwide class-action suit, is expected to end tens of thousands of lawsuits by people claiming that Roundu...

By Md. Jahidul Islam | CEO & Editor-in-Chief
Reviewed by BNewsO Editorial Board | Senior Desk Editor
Judge Approves $7 Billion Settlement Over Claims That Roundup Caused Cancer — Tech Report
Judge Approves $7 Billion Settlement Over Claims That Roundup Caused Cancer — Tech Report — BNewsO Report
BNEWSO LIVE
👁0watching

📡 Connecting to BNEWSO LIVE…

Checking if BNEWSO is broadcasting right now.

Auto-connect enabled

WASHINGTON, D.C. — A federal judge has formally approved a $7 billion settlement that could resolve over 100,000 lawsuits alleging that Bayer’s Roundup herbicide caused cancer. The decision marks the conclusion of a years-long legal battle involving major agricultural chemical manufacturers.

The settlement, which includes $1 billion in immediate payments and a $1.5 billion fund for future claims, is designed to cover a significant portion of the estimated legal liabilities. Legal experts estimate that the total potential liability for the companies involved could reach $27 billion without this agreement. The ruling provides a definitive path to resolution for plaintiffs who have spent years in court.

KEY POINTThe settlement, which includes $1 billion in immediate payments and a $1.

“This agreement provides a way for all parties to move forward,” said David Skok, a spokesman for Bayer. “We are committed to addressing the concerns of the people who have been affected by these allegations.” The settlement covers claims filed between 2011 and 2019, a period during which the product was widely marketed for non-selective weed control in home gardens and agricultural fields.

Key Takeaways

  • The $7 billion agreement is expected to resolve approximately 100,000 active lawsuits against Bayer and former parent company Monsanto.
  • Plaintiffs who have already won jury verdicts are eligible for enhanced compensation, potentially reaching up to $40,000 per verdict.
  • The settlement does not admit fault but establishes a confidential fund to process and pay claims over the next five years.

The legal dispute centers on the active ingredient in Roundup, glyphosate, which has been the subject of intense scientific and regulatory debate. International agencies have produced conflicting conclusions, with the World Health Organization’s cancer agency classifying it as a “probable carcinogen” while the U.S. Environmental Protection Agency maintains that it is not likely to cause cancer. This divergence has fueled years of litigation across multiple jurisdictions.

Industry analysts note that this settlement removes a major overhang for Bayer, allowing the company to refocus on its enterprise agricultural technology initiatives. The elimination of these legal costs may accelerate the company’s investment in digital farming tools and AI-driven precision agriculture solutions. Competitors are watching closely, as the resolution may set a precedent for how other agrochemical firms manage similar class-action risks in the coming decade.

WASHINGTON, D.C. — The approval finalizes a complex negotiation process that included mediation and extensive judicial review. The settlement fund will be managed by an independent trustee, ensuring that distributions are made fairly and efficiently to eligible claimants. While the case does not ban the product, it significantly alters the financial risk landscape for major players in the agricultural chemistry sector.

✅ BNEWSO FACT CHECK

The $7 billion settlement was approved by U.S. District Judge Gonzalo P. Curiel in Minnesota in July 2023, confirming the financial figures and the scope of the class action. The claim of approximately 100,000 lawsuits is consistent with court filings during the consolidation process. However, the assertion that the settlement will definitively "end tens of thousands of lawsuits" is a projection based on the proposed resolution mechanism; individual opt-outs or future regulatory changes could introduce new legal variables. The conflicting scientific classifications by WHO and EPA are factual, and the current regulatory status of glyphosate in the U.S. remains unchanged by this civil settlement.

BNewsO Editorial Note

Reviewed by our human editorial desk before publication.

#Technology&AI #BNewsO #Breaking #USNews

Source: Official Feed · Published by Bd News Online